Key takeaways:
- Researchers report that despite 6 decades of contraceptive innovation, global unmet need remains high, with approximately half of pregnancies worldwide still unintended.
- Significant regional disparities persist, with modern contraceptive use ranging from 40% to 83% in parts of Africa compared with up to 89% in high-income European countries.
- Male participation in contraception remains minimal, and no new male-focused methods have reached the market in over a century, though 2 reversible options are now in clinical trials.
- Adolescents, marginalized communities, transgender and non-binary individuals, and those facing stigma or financial barriers experience disproportionate challenges in accessing contraception.
- Experts emphasize improved education, expanded research funding, provider training, and seamless transitions to hormone therapy as critical strategies to reduce unplanned pregnancies and enhance reproductive autonomy.
In a recent article published in The Lancet, researchers have highlighted gaps in contraception access and associated barriers, indicating sources of unplanned pregnancies and abortions.1
These gaps have remained despite significant advances in contraception within the past 60 years, leading to a new era of contraception research. The researchers made a call to action for immediate attention to be provided to underserved populations such adolescent girls and young women, men, and transgender and nonbinary populations.
“Despite major advances in contraceptive technologies over more than half a century, substantial unmet needs remain,” said Deborah Anderson PhD, professor at Boston University and lead researcher. “In recent years, approximately 50% of pregnancies worldwide have been unintended, leading to a high rate of abortion.”
Variability in contraceptive use
In 2024, 57% of reproductive-aged women completing a survey in the United Kingdom expressed a present desire to avoid pregnancy. Use of a modern contraception method was reported by 77% of these women, while 15% did not use any method of contraception.
Significant disparities in modern contraception use based on region have also been reported, with a range of 40% to 83% reported in some regions of Africa vs 77% to 89% in high-income European countries. Additionally, men comprise less than 25% of the population using contraception, with only 2% of men worldwide undergoing vasectomy.
Male condom use as the primary contraception method is also reported in only 20% of couples. Hormonal contraceptives such as pills, implants, rings, injections, and hormonal intrauterine devices have been proven to have great efficacy, but significant adverse effects have been indicated.
Adverse effects and other barriers
These side effects have been reported as significant barriers to hormonal contraceptive use. Investigators have also highlighted additional barriers to contraceptive use such as religious beliefs, individual or social opposition, and infrequent sex.
According to Anderson, marginalized families and communities are more likely to experience adolescent pregnancies, though this type of pregnancy remains a challenge in all countries. Barriers providing additional challenges toward contraceptive access in adolescents include lack of education, restrictive policies, stigma, and financial hardship.
Investigators also noted a lack of male-focused contraception, with no new methodologies for this population entering the market in over 100 years. Transgender and nonbinary patients, especially those who have not received gender-affirming surgeries, are also at risk of pregnancy when engaging in sexual activity.
Recommendations to address contraceptive gaps
Anderson concluded there has been stagnation in contraception use over the past 25 years. Therefore, she and her colleagues recommended steps be taken to address these gaps, such as the following: